Insider · CIK 0002145064
Gary S. Stetz II
Files at HEPA (Hepion Pharmaceuticals, Inc.). First filing Aug 12, 2026, latest Aug 12, 2026.
In brief
Gary S. Stetz II files SEC Form 4 as director at HEPA (Hepion Pharmaceuticals, Inc.). Since Aug 12, 2026, Gary S. Stetz II has reported 1 open-market buy worth $25k and 0 open-market sells worth $0, the latest filed on Aug 12, 2026.
A track record needs three past buys with six months of prices behind them; Gary S. Stetz II has 0, so none is measured yet.
The newest scored trade: bought $25k of HEPA on Aug 3, 2026, filed Aug 12, 2026, scored 47 (moderate). In the last 12 months: 1 buy worth $25k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HEPA: Hepion Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 47Moderate | Hepion Pharmaceuticals, Inc. | $25k 500,000 shares | - | +106% from low-24% from high |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | HEPA Hepion Pharmaceuticals, Inc. | AGrant or award Stock Optionsderivative | +299,000 | $0.00 | $0 | 299,000 | Aug 21, 2026 |
| Aug 3, 2026 | HEPA Hepion Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +500,000 | $0.05 | $25k | 500,000 | Aug 12, 2026 |
| Aug 3, 2026 | HEPA Hepion Pharmaceuticals, Inc. | POpen-market purchase Warrantsderivative | +500,000 | $0.00 | $0 | 500,000 | Aug 12, 2026 |
Questions about Gary S. Stetz II
Answered from the filings on this page, as of the latest one.
Is Gary S. Stetz II buying or selling?
In the last 12 months Gary S. Stetz II reported 1 open-market buy worth $25k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $25k of HEPA on Aug 3, 2026. Grants, option exercises and tax withholding are not counted.
How did Gary S. Stetz II's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gary S. Stetz II has 0.
Where does Gary S. Stetz II file Form 4?
Gary S. Stetz II has filed Form 4 at HEPA (Hepion Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.